Evidence map›Paper›PMID 35038081›Full record

ArticleMetabolic brain disease2022

EIF4A3-induced circCCNB1 (hsa_circ_0001495) promotes glioma progression by elevating CCND1 through interacting miR-516b-5p and HuR.

Xiaoli Li, Chengmou Wang, Guanghui Chen, Wenqin Zou, Yanqing Deng, Faming Zhou

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolic brain disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Translation of circular RNAs.Nucleic acids research · 2025
    Review
  4. RNA-Binding Proteins (RBPs) and Circular RNA Biogenesis.Advances in experimental medicine and biology · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Circular RNAs in Cell Cycle Regulation of Cancers.International journal of molecular sciences · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xiaoli Li *Department of Neurology, Renmin Hospital, Hubei University of Medicine, No. 39, Chaoyang Middle Road, Maojian District, Shiyan, 442000, China.
Chengmou Wang *Department of Neurology, Renmin Hospital, Hubei University of Medicine, No. 39, Chaoyang Middle Road, Maojian District, Shiyan, 442000, China.
Guanghui ChenDepartment of Neurology, Renmin Hospital, Hubei University of Medicine, No. 39, Chaoyang Middle Road, Maojian District, Shiyan, 442000, China.
Wenqin ZouDepartment of Neurology, Renmin Hospital, Hubei University of Medicine, No. 39, Chaoyang Middle Road, Maojian District, Shiyan, 442000, China.
Yanqing DengDepartment of Neurology, Renmin Hospital, Hubei University of Medicine, No. 39, Chaoyang Middle Road, Maojian District, Shiyan, 442000, China.
Faming ZhouDepartment of Neurology, Renmin Hospital, Hubei University of Medicine, No. 39, Chaoyang Middle Road, Maojian District, Shiyan, 442000, China. fmzhou002@163.com.
Hubei University of Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To explore the functions of circRNA cyclin B1 (circCCNB1) in glioma and its possible mechanisms. The expression of circCCNB1, eukaryotic translation initiation factor 4A3 (EIF4A3), cyclin D1 (CCND1) and miR-516b-5p was determined by qRT-PCR, western blot or immunohistochemistry (IHC) assay. The feature of circCCNB1 was analyzed by Actinomycin D (ActD), RNase R and subcellular fraction assays. The molecule relationships were analyzed by RIP, dual-luciferase reporter and RNA pull-down assays. CCK-8, EdU and colony formation assays were performed to analyze cell proliferation. Flow cytometry analysis was executed to estimate the cell cycle. Murine xenograft model assay was used for the role of circCCNB1 in vivo. CircCCNB1 was overexpressed in glioma tissues and cells. EIF4A3 positively regulated circCCNB1 expression. CircCCNB1 knockdown repressed glioma cell proliferation and cell cycle process in vitro and blocked tumor growth in vivo. CircCCNB1 knockdown reduced CCND1 expression in glioma cells and CCND1 overexpression bated the effect of circCCNB1 knockdown on glioma cell growth. CircCCNB1 interacted with HuR to elevate CCND1 expression. miR-516b-5p could interact with circCCNB1 and CCND1. CircCCNB1 regulated glioma cell progression and CCND1 expression by miR-516b-5p and HuR. CircCCNB1 aggravated glioma cell growth by elevating CCND1 through targeting miR-516b-5p and HuR.

Indexed as

GliomaMicroRNAsAnimalsCell Line, TumorCell ProliferationCyclin B1Cyclin D1DEAD-box RNA HelicasesELAV-Like Protein 1Eukaryotic Initiation Factor-4AHumansMiceRNA, CircularCCND1 protein, humanCyclin B1Cyclin D1DEAD-box RNA HelicasesEIF4A3 protein, humanELAVL1 protein, humanELAV-Like Protein 1Eukaryotic Initiation Factor-4AMicroRNAsMIRN516 microRNA, humanRNA, CircularCCND1circCCNB1GliomaHuRmiR-516b-5p

Identifiers

PMID35038081
OpenAlexW4205788798

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.